Alper Biotech, LLC

Alper Biotech is a biotechnology company specializing in the identification, development and commercialization of novel highly-specific monoclonal antibody-based diagnostic assays in cancer.

Alper's monoclonal antibodies uniquely recognize proteins that are modified and differentially expressed in cancer cells. This novel and proprietary approach to cancer diagnostics will be applied to a variety of research and clinical testing applications.

Alper's pipeline of cancer diagnostic kits will cover many tumor types starting with breast cancer and expanding into other tumors of major concern to Oncologists. Alper's monoclonal antibodies are selected to help address high unmet medical needs in managing cancer diagnosis today.